Pure Bioscience (PURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 10-1998 | 07-1998 | 04-1998 | 01-1998 | 10-1997 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 240 | 250 | 300 | 680 | N/A |
| Marketable Securities | 0 | 0 | 0 | 0 | 1,270 |
| Receivables | 630 | 270 | 180 | 270 | 570 |
| Inventories | 520 | 360 | 120 | 80 | 60 |
| Other current assets | 150 | 130 | 510 | 960 | 570 |
| TOTAL | $1,540 | $1,010 | $1,110 | $1,990 | $2,470 |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 0 | 0 | 0 | 20 |
| Other Non-Current Assets | 1,070 | 1,150 | 570 | 580 | 40 |
| TOTAL | $1,070 | $1,150 | $570 | $580 | $60 |
| Total Assets | $3,440 | $2,970 | $2,470 | $3,380 | $3,330 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 650 | 490 | 200 | 150 | 210 |
| Accrued Expenses | 6 | 40 | 50 | 1 | 30 |
| TOTAL | $1,170 | $830 | $430 | $250 | $240 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,170 | $830 | $430 | $250 | $240 |
| Shareholders' Equity | |||||
| Common Shares | 6,230 | 6,230 | 6,120 | 6,120 | 5,560 |
| Retained earnings | -3,960 | -4,100 | -4,080 | -2,990 | -2,580 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 100 |
| TOTAL | $2,270 | $2,130 | $2,040 | $3,130 | $3,080 |
| Total Liabilities And Equity | $3,440 | $2,960 | $2,470 | $3,380 | $3,320 |